{
    "2020-09-12": [
        [
            {
                "time": "",
                "original_text": "医药生物行业:基本面无虞 Q4有望反转",
                "features": {
                    "keywords": [
                        "医药生物",
                        "基本面",
                        "Q4",
                        "反转"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "迈瑞医疗：行业龙头优势突出 面临良好的政策和市场机遇期",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "行业龙头",
                        "政策",
                        "市场机遇"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}